Oscillo Biosciences
Oscillo Biosciences is an early stage company whose mission is to awaken hope for all people living with Alzheimer's Disease and related disorders by developing effective, affordable, non-invasive, non-pharmacological treatments that harness the power of music and neuroscience to stimulate change in the brain.
Groundbreaking neuroscientific research on brain rhythms is offering new hope for this incurable disease. At Oscillo Biosciences, we are harnessing the power of music and synchronized light to stimulate brain rhythms, awakening memory and cognitive function previously thought to be permanently lost.
Alzheimer’s Disease is a Global Epidemic.
In the United States today, nearly 6 million people suffer from dementia due to Alzheimer’s disease. For these people, what began with mild memory loss and confusion has progressively worsened, and will eventually leave them unable to carry on a conversation or perform simple tasks. In time, they will require around-the-clock care. The effects are as devastating for families and caregivers as they are for patients.
Alzheimer’s disease is the sixth leading cause of death in America. And despite billions spent on research and pharmaceutical interventions, there is no cure.
The number of cases is projected to more than double to 6 million in the next 30 years.
12 million people suffer from Mild Cognitive Impairment, a precursor to Alzheimer’s dementia.
25 million people have preclinical Alzheimer’s disease—the biomarkers are there, but symptoms have not yet appeared.
Take Part in Our Clinical Study
We are conducting a Phase 1 study to evaluate the effectiveness of music and multisensory stimulation on brain activity in adults who are experiencing memory loss. If you are over 50, live in the Boston area, and are experiencing memory loss, you may be eligible to participate.
Looking Beyond Pharmaceuticals
At Oscillo Biosciences, we are approaching Alzheimer’s disease with fresh eyes and ears. We are marrying the power of music with a rhythmic visual experience to activate multiple areas of the brain at multiple frequencies, especially those involved in memory and cognition.
Recognized and supported by the National Science Foundation, our patented non-invasive, non-pharmaceutical digital therapy is the first to combine neural stimulation from music with synchronized light to restore healthy brain rhythms in people with dementia.
.jpg)
Oscillo Biosciences is an early stage company whose mission is to preserve and restore memory and cognition in people with Alzheimer’s disease and related dementias.